Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics

Detalhes bibliográficos
Autor(a) principal: Celiberto, Larissa S. [UNESP]
Data de Publicação: 2018
Outros Autores: Pinto, Roseli Aparecida [UNESP], Rossi, Elizeu Antonio [UNESP], Vallance, Bruce A., Cavallini, Daniela C U [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.3390/nu10111684
http://hdl.handle.net/11449/188331
Resumo: Modulation of the gut microbiota through the use of probiotics has been widely used to treat or prevent several intestinal diseases. However, inconsistent results have compromised the efficacy of this approach, especially in severe conditions such as inflammatory bowel disease (IBD). The purpose of our study was to develop a personalized probiotic strategy and assess its efficacy in a murine model of intestinal inflammation. Commensal bacterial strains were isolated from the feces of healthy mice and then administered back to the host as a personalized treatment in dextran sodium sulfate (DSS)-induced colitis. Colonic tissues were collected for histological analysis and to investigate inflammatory markers such as Il-1β, Il-6, TGF-β, and Il-10, and the enzyme myeloperoxidase as a neutrophil marker. The group that received the personalized probiotic showed reduced susceptibility to DSS-colitis as compared to a commercial probiotic. This protection was characterized by a lower disease activity index and reduced histopathological damage in the colon. Moreover, the personalized probiotic was more effective in modulating the host immune response, leading to decreased Il-1β and Il-6 and increased TGF-β and Il-10 expression. In conclusion, our study suggests that personalized probiotics may possess an advantage over commercial probiotics in treating dysbiotic-related conditions, possibly because they are derived directly from the host's own microbiota.
id UNSP_4874b2d5e5595702d3ed9fcc4b28c87b
oai_identifier_str oai:repositorio.unesp.br:11449/188331
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized ProbioticsBifidobacteriumcolitisIBDLactobacillusmicrobiotamicrobiota biobankpersonalized probioticModulation of the gut microbiota through the use of probiotics has been widely used to treat or prevent several intestinal diseases. However, inconsistent results have compromised the efficacy of this approach, especially in severe conditions such as inflammatory bowel disease (IBD). The purpose of our study was to develop a personalized probiotic strategy and assess its efficacy in a murine model of intestinal inflammation. Commensal bacterial strains were isolated from the feces of healthy mice and then administered back to the host as a personalized treatment in dextran sodium sulfate (DSS)-induced colitis. Colonic tissues were collected for histological analysis and to investigate inflammatory markers such as Il-1β, Il-6, TGF-β, and Il-10, and the enzyme myeloperoxidase as a neutrophil marker. The group that received the personalized probiotic showed reduced susceptibility to DSS-colitis as compared to a commercial probiotic. This protection was characterized by a lower disease activity index and reduced histopathological damage in the colon. Moreover, the personalized probiotic was more effective in modulating the host immune response, leading to decreased Il-1β and Il-6 and increased TGF-β and Il-10 expression. In conclusion, our study suggests that personalized probiotics may possess an advantage over commercial probiotics in treating dysbiotic-related conditions, possibly because they are derived directly from the host's own microbiota.Crohn's and Colitis CanadaFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Canadian Institutes of Health ResearchDepartment of Food and Nutrition School of Pharmaceutical Sciences São Paulo State University (UNESP)Division of Gastroenterology Department of Pediatrics BC Children's Hospital and the University of British ColumbiaDepartment of Food and Nutrition School of Pharmaceutical Sciences São Paulo State University (UNESP)Crohn's and Colitis Canada: -FAPESP: 2014/15129-1Canadian Institutes of Health Research: PJT 148846 and 159528Universidade Estadual Paulista (Unesp)BC Children's Hospital and the University of British ColumbiaCeliberto, Larissa S. [UNESP]Pinto, Roseli Aparecida [UNESP]Rossi, Elizeu Antonio [UNESP]Vallance, Bruce A.Cavallini, Daniela C U [UNESP]2019-10-06T16:04:40Z2019-10-06T16:04:40Z2018-11-05info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.3390/nu10111684Nutrients, v. 10, n. 11, 2018.2072-6643http://hdl.handle.net/11449/18833110.3390/nu101116842-s2.0-85056262710Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengNutrientsinfo:eu-repo/semantics/openAccess2024-06-21T12:46:50Zoai:repositorio.unesp.br:11449/188331Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T18:02:24.558315Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics
title Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics
spellingShingle Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics
Celiberto, Larissa S. [UNESP]
Bifidobacterium
colitis
IBD
Lactobacillus
microbiota
microbiota biobank
personalized probiotic
title_short Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics
title_full Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics
title_fullStr Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics
title_full_unstemmed Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics
title_sort Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics
author Celiberto, Larissa S. [UNESP]
author_facet Celiberto, Larissa S. [UNESP]
Pinto, Roseli Aparecida [UNESP]
Rossi, Elizeu Antonio [UNESP]
Vallance, Bruce A.
Cavallini, Daniela C U [UNESP]
author_role author
author2 Pinto, Roseli Aparecida [UNESP]
Rossi, Elizeu Antonio [UNESP]
Vallance, Bruce A.
Cavallini, Daniela C U [UNESP]
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
BC Children's Hospital and the University of British Columbia
dc.contributor.author.fl_str_mv Celiberto, Larissa S. [UNESP]
Pinto, Roseli Aparecida [UNESP]
Rossi, Elizeu Antonio [UNESP]
Vallance, Bruce A.
Cavallini, Daniela C U [UNESP]
dc.subject.por.fl_str_mv Bifidobacterium
colitis
IBD
Lactobacillus
microbiota
microbiota biobank
personalized probiotic
topic Bifidobacterium
colitis
IBD
Lactobacillus
microbiota
microbiota biobank
personalized probiotic
description Modulation of the gut microbiota through the use of probiotics has been widely used to treat or prevent several intestinal diseases. However, inconsistent results have compromised the efficacy of this approach, especially in severe conditions such as inflammatory bowel disease (IBD). The purpose of our study was to develop a personalized probiotic strategy and assess its efficacy in a murine model of intestinal inflammation. Commensal bacterial strains were isolated from the feces of healthy mice and then administered back to the host as a personalized treatment in dextran sodium sulfate (DSS)-induced colitis. Colonic tissues were collected for histological analysis and to investigate inflammatory markers such as Il-1β, Il-6, TGF-β, and Il-10, and the enzyme myeloperoxidase as a neutrophil marker. The group that received the personalized probiotic showed reduced susceptibility to DSS-colitis as compared to a commercial probiotic. This protection was characterized by a lower disease activity index and reduced histopathological damage in the colon. Moreover, the personalized probiotic was more effective in modulating the host immune response, leading to decreased Il-1β and Il-6 and increased TGF-β and Il-10 expression. In conclusion, our study suggests that personalized probiotics may possess an advantage over commercial probiotics in treating dysbiotic-related conditions, possibly because they are derived directly from the host's own microbiota.
publishDate 2018
dc.date.none.fl_str_mv 2018-11-05
2019-10-06T16:04:40Z
2019-10-06T16:04:40Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.3390/nu10111684
Nutrients, v. 10, n. 11, 2018.
2072-6643
http://hdl.handle.net/11449/188331
10.3390/nu10111684
2-s2.0-85056262710
url http://dx.doi.org/10.3390/nu10111684
http://hdl.handle.net/11449/188331
identifier_str_mv Nutrients, v. 10, n. 11, 2018.
2072-6643
10.3390/nu10111684
2-s2.0-85056262710
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Nutrients
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128888646139904